Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.
NCT01275443
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
300mg TMC278LA
DRUG:
150mg TMC278LA
DRUG:
1200mg TMC278LA
DRUG:
600mg TMC278LA
Sponsor
St Stephens Aids Trust